Polarean Imaging PLC on Friday said it has received its second de novo order for a new Xenon MRI system from the University of Alabama at Birmingham Hospital in the US.

Shares in Polarean were up 37% at 4.72 pence each in London on Friday morning.

The London-based medical imaging technology developer said it expects to install the new system later this year and will collaborate ‘closely’ with the hospital team, as it does with its existing clinical sites, to develop a ‘strong’ Xenon MRI programme.

This programme will support clinical imaging, NIH-funded research, and pharmaceutical-sponsored trials, Polarean said, aligning with its commitment to advancing medical research and patient care.

Copyright 2024 Alliance News Ltd. All Rights Reserved.